NCT05137054 2026-01-22A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care TreatmentsRegeneron PharmaceuticalsPhase 1 Recruiting317 enrolled